Accessibility Menu
Strainsforpains logo

Strainsforpains(OTC) EBYH

Market Cap$2.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)-100%
5 Year-65%
1 Year+15%
1 Month+24%
$0.21
-13.3%
-0.03Today
Strainsforpains last closing stock price
MetricPriceDate
Last closeUSD 0.212026-07-28
Strainsforpains stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+16.67%USD 0.182026-07-10
1 month+23.53%USD 0.172026-06-26
3 month+29.15%USD 0.162026-04-27
Year to date+30.84%USD 0.162025-12-18
1 year+14.75%USD 0.182025-07-17
3 year-11.76%USD 0.242023-07-26
5 year-64.97%USD 0.602021-07-29
Since inception-100%USD 4,980.471999-06-08

Strainsforpains Financials at a Glance

Market Cap

$2.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$40.19K

Net Income (TTM)

-$157.45K

EPS (TTM)

-$0.01

P/E Ratio

-19.44

Dividend

$0.00

Beta (Volatility)

0.12 (Low)

Price

$0.21

Volume

5,000

Open

$0.21

Previous Close

$0.21

Daily Range

$0.21 - $0.21

52-Week Range

$0.16 - $0.24

Estimated Earnings Date

N/A

EBYH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Strainsforpains

Strainsforpains, Inc. is an innovative data-driven platform specializing in medical cannabis recommendations. The company offers a user-centric application that analyzes patient data and cannabis strain profiles to provide tailored recommendations.

Products and Services
  • Strainsforpains application for personalized cannabis recommendations
  • Services for healthcare practitioners and cannabis dispensaries
  • Data analytics for individual end-consumers
Growth Outlook
  • Revenue increased from $3,017 in Q1 to $48,808 in Q4 2025
  • Significant user engagement growth expected in the medical cannabis sector
  • Expansion plans targeting new markets and partnerships with dispensaries
Financial Highlights
  • Trailing twelve months (TTM) revenue of $48,808, showing upward momentum
  • Current ratio of 7.87 indicates strong liquidity position
  • Net income improved from -$71,217 in Q3 to -$46,883 in Q4 2025
Strainsforpains, Inc. operates within the healthcare information services sector, focusing on the burgeoning medical cannabis market. The company's flagship application leverages data analytics to enhance patient care by providing personalized cannabis strain recommendations. This innovative approach positions Strainsforpains as a key player in a rapidly evolving industry. The growth outlook for Strainsforpains is promising, with a notable increase in revenue over the past quarters. The company is poised to capitalize on the expanding acceptance and legalization of medical cannabis, which is expected to drive user engagement and revenue growth. Strategic partnerships with healthcare practitioners and dispensaries further enhance the potential for market penetration. Financially, Strainsforpains has demonstrated resilience, with a significant increase in revenue and a strong liquidity position. The current ratio of 7.87 indicates that the company is well-equipped to meet its short-term obligations. Although net income remains negative, the improvement from previous quarters suggests a positive trend towards profitability. Overall, Strainsforpains, Inc. presents an intriguing opportunity for investors interested in the intersection of technology and healthcare, particularly within the medical cannabis sector.
AI Generated • Jul 11, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Yehoshua Simon Shainberg

Website

www.strainsforpains.com

Headquarters

New York City, NY 10001, US

EBYH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

-101.68%

Net Income Margin

-391.75%

Return on Equity

14.49%

Return on Capital

-4.94%

Return on Assets

-9.06%

Earnings Yield

-5.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.92M

Volume

5.00K

Avg. Volume

2.14K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$40.87K

EBITDA

-$40.87K

Operating Cash Flow

-$188.91K

Capital Expenditure

$1.80

Free Cash Flow

-$188.91K

Cash & ST Invst.

$7.94K

Total Debt

$1.96M

Strainsforpains Performance Analysis

Strainsforpains annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 7,393-18.8%
20232023-12-31USD 84,1171037.8%
20242024-12-31USD 180,228114.3%
20252025-12-31USD 40,191-77.7%
Strainsforpains sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-56.5%
Q22025-06-30125.4%
Q32025-09-30276.0%
Q42025-12-31-81.2%
Strainsforpains annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-15.2%
20232023-12-31USD -0.01-24.3%
20242024-12-31USD -0.00-83.2%
20252025-12-31USD -0.01386.4%
Strainsforpains sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-10.3%
Q22025-06-303.1%
Q32025-09-3061.3%
Q42025-12-31-166.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.81K

-30.7%

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$46.88K

-12.0%

EBITDA

-$17.74K

-39.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$7.94K

+316.8%

Total Debt

$1.96M

+0.0%

Accounts Receivable

$225.00K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$1.96M

+0.0%

Short Term Debt

$0.00

N/A

Return on Assets

-9.06%

N/A

Return on Invested Capital

-2.39%

N/A

Free Cash Flow

-$41.85K

+41.2%

Operating Cash Flow

-$41.85K

+41.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
YBGJYubo International Biotech Limited
$0.01+0.00%
HESGHealth Sciences Group, Inc.
$0.00+0.00%
CSOCCaduceus Software Systems Corp.
$0.00+0.00%
AGTXAgentix Corp.
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.13+0.11%
NVDANvidia
$195.04+0.03%
MSFTMicrosoft
$451.10+0.16%
NOKNokia
$9.09+0.08%

Questions About EBYH

What is the current price of Strainsforpains?

Strainsforpains is trading at $0.21 per share.

What is the 52-week range for Strainsforpains?

Over the past 52 weeks, Strainsforpains has traded between $0.16 and $0.24.

How much debt does Strainsforpains have?

As of the most recent reporting period, Strainsforpains reported total debt of $1.96M.

How much cash does Strainsforpains have on hand?

Strainsforpains reported $7.94K in cash and cash equivalents in its most recent financial results.

What is Strainsforpains’s dividend yield?

Strainsforpains does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services